2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Cancer genetics<br />
genes . One <strong>of</strong> them had two additional unbalanced translocations,<br />
t(12;14)(p;q11) and t(12;16)(p;p) with complex karyotype such as<br />
45,XY,-14,t(11;17)(q23;q21),der(12)t(12;14)(p11;q11),der(16)t(?12;1<br />
6)(p11;q13) in 96% cells . It has been reported that such variant cases<br />
are resistant to ATRA and exhibit no therapeutic response, though<br />
resemble PML-RARA morphologically. Therefore, these two patients<br />
are presumed to experience poor prognosis . Investigation <strong>of</strong> all these<br />
cases by FISH for PML-RARA would have given normal result to these<br />
two patients and could have led to progression <strong>of</strong> the disease condition<br />
. Therefore, it´s understood that conventional cytogenetics still<br />
plays an important role in diagnosis, classification, prognostication and<br />
monitoring <strong>of</strong> hematologic malignancies in the era <strong>of</strong> microarray technology<br />
and cannot be replaced by any other molecular technique .<br />
P04.077<br />
cytogenetic study <strong>of</strong> chronic myeloid leukemia (cmL)<br />
R. Joshi, B. B. Ganguly;<br />
MGM Centre for Genetic Research & Diagnosis, New Bombay, India.<br />
To explore the clinical cytogenetic feature & prognosis <strong>of</strong> chronic<br />
myeloid leukemia patient, evaluation <strong>of</strong> 8 CML cases (6 men and 2<br />
women) from the indian population with ages ranging from 25 to 55<br />
years were studied in the present dissertation project . Bone marrow<br />
samples were processed following direct method &/or 24hrs culture<br />
without mitogen for chromosome preparation and karyotype analysis<br />
<strong>of</strong> G-banded metaphases . 25 metaphases were studied for each<br />
case using karyotyping s<strong>of</strong>tware (Metasystems, Germany) . All 8 cases<br />
showed Philadelphia chromosome i .e . t(9;22)(q34;q11) in 100% cells .<br />
Two (25%) cases showed extra Philadelphia chromosome in 8% &<br />
38% cells respectively . One case had missing <strong>of</strong> Y chromosome in<br />
addition to Philadelphia chromosome . It has been established that the<br />
major secondary chromosomal abberation in adult is double philadelphia<br />
chromosome & minor one is -Y chromosome . The i(17)q is not<br />
very common in adult . Since chromosome 17 was normal in all the<br />
above cases the prognosis <strong>of</strong> these patients will be comparetively better<br />
. However, the prognosis <strong>of</strong> patient in which abnormal metaphase<br />
with +ph chromosome was 38% expected to be poor compared to the<br />
patient with 8 .6% abnormal metaphases . Due to the additional chromosomal<br />
abnormality, patient may aquire resistance to Imatinib - the<br />
tyrosine kinase inhibitor . Therefore, it is understood that cytogenetic<br />
study is important in diagnosis & prognostication <strong>of</strong> CML patient .<br />
P04.078<br />
Another case with der(8)t(8;17)(p11;q11) in sézary’s syndrome<br />
A. Valera1,1 , A. Carrió1 , D. Costa1 , A. Arias1 , M. Rozman1 , M. Aymerich1 , D.<br />
Colomer1 , P. Abrisqueta2 , F. Bosch2 , T. Estrach3 , E. Campo1 ;<br />
1Unitat d’Hematopatologia. Hospital Clínic de <strong>Barcelona</strong>., <strong>Barcelona</strong>, Spain,<br />
2 3 Servei d’Hematologia.Hospital Clínic de <strong>Barcelona</strong>, <strong>Barcelona</strong>, Spain, Servei<br />
de Dermatologia.Hospital Clínic de <strong>Barcelona</strong>, <strong>Barcelona</strong>, Spain.<br />
Sézary’s syndrome (SS) is a peripheral T-cell neoplasm characterized<br />
by a pruritic exfoliative or infiltrated erythroderma, lymphadenopaties,<br />
and atypical T lymphocytes in the periphereal blood . Chromosome<br />
abnormalities, mostly complex karyotypes, are seen in about 50% <strong>of</strong><br />
patients with SS, and there have only been a few instances <strong>of</strong> recurrent<br />
rearrangements .<br />
We report a 60 year-old female referred to Hematology Service due to<br />
20 months history <strong>of</strong> lymphocytosis . The patient showed a cutaneous<br />
hyperpigmentation and bilateral axillary and inguinal lymphadenopaties<br />
. The peripheral blood smear presented 40% <strong>of</strong> Sézary cells . The<br />
diagnosis was Mycosis Fungoide with leukemic involvement .<br />
The karyotype in peripheral blood was performed . We used G-banded<br />
technique in conventional cytogenetics . Molecular cytogenetics<br />
(FISH analysis) permitted discovering the rearrangements involved .<br />
The whole chromosome paints (WCPs) for chromosomes 1, 5, 9, 10,<br />
11, 15, 17 and 19 were used . Finally the karyotype was: 44-45, XX,<br />
t(1;5)(p33;q31)[4], der(8)t(8;17)(p11;q11)[4], -9[2], inv(9)(p21;q34)[2],<br />
-10[4], del(11)(q21)[4], der(14)t(10;14)(?q?;p11)[4], del(15)(q22)[4],<br />
der(15)t(9;15)(q21;q26)[2], -17[4], +mar1[4] [cp4] / 45, X, -X[6] /<br />
46,XX[10] .<br />
Cytogenetic alterations were concordant with other abnormalities described<br />
before in SS, like: breakpoints at 1p32-36 and 10q23-26, and<br />
other alterations involving chromosomes 8, 9, 11 and 17 . But the most<br />
important event was the presence <strong>of</strong> der(8)t(8;17)(p11;q11), because<br />
to our knowledge, this is the fourth case with the same alteration re-<br />
ported in SS . First <strong>of</strong> all was Thangavelu M, et al . Blood (1997) with<br />
two cases with der(8)t(8;17)(p11;q11) and a psu dic(17;8)(p11 .2;p11 .2)<br />
was observed by Batista D, et al . Genes, Chromosomes and Cancer<br />
(2006) .<br />
P04.079<br />
Der(1;16)(q10;p10) in Acute Myeloid Leukemia: the first female<br />
case described<br />
N. Kokalj Vokac1 , A. Zagorac1 , A. Erjavec Skerget1 , Z. Roskar1 , H. Podgornik2 ,<br />
P. Cernelc2 ;<br />
1 2 University Medical Centre Maribor, 2000 Maribor, Slovenia, University Medical<br />
Centre Ljubljana, 1000 Ljubljana, Slovenia.<br />
Whole-arm translocation <strong>of</strong> chromosome 1 and 16 is recurrently observed<br />
in non-hematologic neoplasias such as breast carcinomas and<br />
Ewings sarcoma but rarely in hematologic neoplasias, mostly in multiple<br />
myelomas . To our knowledge, only 7 cases were described in<br />
MDS/AML, interesting all were males .<br />
Here we describe the first female patient with AML M4/M5 with<br />
der(1;16)(q10;p10) as the sole chromosome rearrangement found .<br />
Cytogenetic examination <strong>of</strong> bone marrow cells revealed that the normal<br />
chromosome 16 was lost and replaced by an abnormal chromosome<br />
consisting <strong>of</strong> the long arm <strong>of</strong> chromosome 1 and the short arm <strong>of</strong><br />
chromosome 16, resulting in trisomy <strong>of</strong> the long arm <strong>of</strong> chromosome<br />
1 and monosomy <strong>of</strong> the long arm <strong>of</strong> chromosome 16 . The karyotype<br />
was confirmed by FISH: 46,XX,+1,der.ish (1;16)(q10;p10)(wcp1+,wcp<br />
16+,cep16+) .<br />
Due to a small number <strong>of</strong> metaphases available and bad resolution <strong>of</strong><br />
chromosomes, CGH was also performed. Only the amplification <strong>of</strong> the<br />
long arm <strong>of</strong> chromosome 1 and deletion <strong>of</strong> the long arm <strong>of</strong> chromosome<br />
16 was confirmed.<br />
Unfavorable outcome, including no response to chemotherapy, and<br />
short survival were characteristic <strong>of</strong> our patient . Despite very short survival<br />
<strong>of</strong> our patient, prognostic significance remains to be determined.<br />
It is possible that some other unidentified molecular mechanism could<br />
play a role in bad prognosis or simply the fact that this is the only<br />
female patient described until now . From this point <strong>of</strong> view, the pathogenesis<br />
<strong>of</strong> der(1;16) still remains unresolved .<br />
P04.080<br />
Detection <strong>of</strong> gene expression pr<strong>of</strong>ile for BAALC and WT1 genes<br />
by real time Rt-PcR in patients with acute myeloid leukemia<br />
L. A. Tamas, E. Seclaman, A. Mihala, A. Neghina, C. Samoila, I. M. Ciuca;<br />
University <strong>of</strong> Medicine and Pharmacy, Timisoara, Romania.<br />
Acute myeloid leukemia (AML) is a heterogeneous group <strong>of</strong> diseases<br />
characterized by uncontrolled proliferation <strong>of</strong> clonal neoplastic hematopoietic<br />
precursor cells and impaired production <strong>of</strong> normal hematopoiesis<br />
leading to neutropenia, anemia, and thrombocytopenia .<br />
High mRNA expression <strong>of</strong> BAALC and WT1 have been shown to be<br />
an adverse risk factor in newly diagnosed AML patients with normal<br />
cytogenetics .<br />
Independent confirmation is required to validate the initial results so<br />
that BAALC and WT1 expression may be exploited for risk-adapted<br />
treatment stratification <strong>of</strong> AML patients with normal cytogenetics.<br />
We analyzed patients selected from newly diagnosed cases <strong>of</strong> AML<br />
and a control group <strong>of</strong> healthy individuals .<br />
Total RNA from leukocytes was extracted from blood samples treated<br />
with RNA-later (QIAGEN) following the manufacturer’s directions<br />
(RiboPure - blood kit, Ambion) . For semiquatitative RT-PCR we used<br />
One-step RT-PCR kit (QIAGEN), with gene-specific, intron spanning<br />
primers for BAALC,WT1 and GPDH as housekeeping gene. Comparative<br />
real-time RT-PCR assays were performed for each sample in triplicate<br />
.<br />
The results showed a significantly increased level <strong>of</strong> expression for<br />
BAALC and WT1genes in de novo acute myeloid leukemia patients<br />
with normal cytogenetics comparative with healthy individuals from the<br />
control group .<br />
In conclusion, the analyse <strong>of</strong> BAALC and WT1 genes expression in<br />
AML patients is a molecular marker which can be used for the evaluation<br />
<strong>of</strong> disease aggressivenes and prognosis for patients with normal<br />
cytogenetics .<br />
Acknowledgements: The study was supported by a romanian research<br />
grant CEEX 5855/2006<br />
0